Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Appendiceal Cancer Treatment Companies

ID: MRFR/Pharma/5042-HCR
100 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Appendiceal cancer is a rare form of cancer that originates in the appendix, a small organ located near the beginning of the large intestine. The treatment for appendiceal cancer often involves surgery, and in some cases, chemotherapy may be recommended.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Appendiceal Cancer Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.81%
2024 Market Size$ 2.61 Billion
2025 Market Size$ 2.81 Billion
2035 Market Size$ 5.97 Billion
Key Players
Bristol Myers Squibb
Merck & Co
Roche
Novartis
Amgen
Eli Lilly and Company
Opportunities
  • Emergence of Personalized Medicine
  • Advancements in Surgical Techniques
  • Growing Investment in Cancer Research

Top Industry Leaders in the Appendiceal Cancer Treatment Market

Appendiceal Cancer Treatment Market
 

Latest Appendiceal Cancer Treatment Companies Updates:

Merck KGaA announces promising early data from a Phase 2 clinical trial of KEYTRUDA® (pembrolizumab) for treating advanced unresectable appendix cancer, showing positive response rates and highlighting the potential of immunotherapy in this setting.

Genentech receives FDA Breakthrough Therapy designation for its investigational antibody-drug conjugate Polatuzumab vedotin, designed for treating patients with locally advanced or metastatic appendiceal cancer who have progressed on prior chemotherapy.

Boston Scientific introduces its portfolio of advanced surgical instruments specifically designed for minimally invasive laparoscopic appendiceal cancer surgery, offering surgeons precision and improved control.

The National Cancer Institute (NCI) partners with academic institutions and pharmaceutical companies to fund research on improving appendiceal cancer diagnosis, treatment, and clinical trials.

List of Appendiceal Cancer Treatment Key companies in the market:

  • AbbVie, Inc.
  • Pfizer Inc.
  • Eli Lilly & Company
  • Bristol-Myers Squibb Company
  • F. Hoffman-La Roche Ltd.
  • Novartis AG
  • General Electric Company
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Bayer AG
  • Amgen Inc.